Amesanar is under clinical development by RHEACELL and currently in Phase II for Diabetic Foot Ulcers. According to GlobalData, Phase II drugs for Diabetic Foot Ulcers does not have sufficient ...
ENERGIF-703 is under clinical development by Energenesis Biomedical and currently in Phase III for Diabetic Foot Ulcers.
If you're suffering from foot pain, did you know it could be 71 other issues instead of plantar facitis? Emily learns why ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback